Data from multiple sources - Curated by Toby Galbraith - Last updated 06 June 2017


An inflammatory condition of the airways, asthma typically presents during childhood. It is very common, and affects hundreds of millions of people worldwide. Asthma is often


Read more on Asthma



Latest news articles

Added 9 days ago Drug news

Phase III LIBERTY ASTHMA QUEST study of dupilumab shows a reduction in severe asthma attacks.- Sanofi + Regeneron.

Sanofi and Regeneron Pharmaceuticals, Inc. announced that the pivotal Phase III LIBERTY ASTHMA QUEST study of dupilumab in a broad...

Added 13 days ago Drug news

PATHWAY Phase II trial of tezepelumab shows reduction in annual asthma exacerbation rate and is published in NEJM.- Medimmune/AstraZeneca + Amgen.

AstraZeneca and Amgen Inc.announced results from the PATHWAY Phase IIb trial of tezepelumab that showed a significant reduction in the...

Added 1 month ago Drug news

FDA approves QVAR RediHaler (beclomethasone dipropionate HFA) inhalation aerosol to treat asthma. Teva Pharma

Teva Pharmaceutical Industries Ltd. announced that the FDA has approved QVAR RediHaler (beclomethasone dipropionate HFA) inhalation aerosol, a breath-actuated inhaler...

Search all news articles for Asthma

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Airway Disease

The Airway Disease Learning Zone is an area where you can access the information about VisionAir and see video presentations from the forum. The Inhalation Technology page features a video presentation from the live broadcast presented by key faculty.

Visit Airway Disease

Allergic Rhinitis

Allergic rhinitis causes great strain on the workforce. Help to reduce sick days and improve productivity with appropriate treatment options.

Visit Allergic Rhinitis


British Guideline on the Management of Asthma

Asthma is a common condition which produces a significant workload for general practice, hospital outpatient clinics and inpatient admissions.

Added 2 years ago

Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases

The present guideline (S2k) on allergen-specific immunotherapy (AIT) was established by the German, Austrian and Swiss professional associations for allergy in consensus with the scientific specialist societies and professional associations...

Added 6 months ago

Japanese Guideline for Adult Asthma 2014

Adult bronchial asthma (hereinafter, asthma) is characterized by chronic airway inflammation, reversible airway narrowing, and airway hyperresponsiveness. Long-standing asthma induces airway remodeling to cause intractable asthma.

Added 5 months ago

Search all guidelines for Asthma

Journal articles

Treating tobacco dependence: guidance for primary care on life-saving interventions. Position statement of the IPCRG.

Tobacco smoking is the world's leading cause of premature death and disability. Global targets to reduce premature deaths by 25% by 2025 will require a substantial increase in the number of smokers making a quit attempt...

Added 2 months ago

Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma.

Background: Many patients with severe asthma rely on oral glucocorticoids to manage their disease. We investigated whether benralizumab, a monoclonal antibody directed against the alpha subunit of the interleukin-5 receptor...

Added 2 months ago

Can anti-IgE therapy prevent airway remodeling in allergic asthma?

Airway remodeling is a central feature of asthma. It is exemplified by thickening of the lamina reticularis and structural changes to the epithelium, submucosa, smooth muscle, and vasculature of the airway wall.

Added 3 months ago

Search all journal articles for Asthma

Clinical trials

Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)

Primary Objective:
- To evaluate the efficacy of dupilumab (SAR231893 / REGN668) in patients with persistent asthma.

Added 6 days ago

A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma.

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy, safety, and immunogenicity of treatment with reslizumab in patients with eosinophilic asthma.

Added 3 months ago

A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma

The primary objective of this study is to determine whether reslizumab is more effective than placebo in reducing the number of clinical asthma exacerbations (CAEs) in patients with eosinophilic asthma.

Added 3 months ago

Search all clinical trials for Asthma
Edzard Ernst

researcher and scourge of alternative medicine; >1000 peer-reviewed papers, 49 books [latest: 'A SCIENTIST IN WONDERLAND'], H-Index > 80, retired, now enthusiastic blogger

But he knows nothing about homeopathy!

Whenever I criticise their methods, homeopaths claim that my arguments are invalid because I know next to nothing about the subject. Is this because they feel threatened by my arguments? Or could it be that the allegation is incorrect?

You can judge for yourself - here is a (slightly shortened and revised) excerpt from my recent memoire ‘A SCIENTIST IN WONDERLAND’ which recounts my exposure to and experience in homeopathy.


Respiratory care clinical Q&A November 2015

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
Registration required
Subscription fee

Management of acute cough in children

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
Registration required
Subscription fee

Easily missed: Occupational asthma

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
Registration required
Subscription fee
Search all CME for Asthma